Altos Biologics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 16

Employees

  • Latest Deal Type
  • 2ndary - Private
  • (Announced)

Altos Biologics General Information

Description

Developer of human hyaluronidase technology designed to facilitate global technology transfer. The company's technology helps in the treatment of various complex health issues, enabling doctors to cure patients' diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 8th floor, 15, Teheran-ro 84-gil
  • Daechi-dong, Simon Tower, Gangnam-gu
  • Seoul, 06179
  • South Korea
Primary Industry
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 8th floor, 15, Teheran-ro 84-gil
  • Daechi-dong, Simon Tower, Gangnam-gu
  • Seoul, 06179
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Altos Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 06-Oct-2026 Announced Generating Revenue
3. Merger/Acquisition 22-May-2025 Completed Generating Revenue
2. Early Stage VC (Series B) 09-Jul-2024 $17.7M $164M Completed Generating Revenue
1. Early Stage VC (Series A) 14-Jan-2021 $146M $146M Completed Generating Revenue
To view Altos Biologics’s complete valuation and funding history, request access »

Altos Biologics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Altos Biologics Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
DS Asset Management Asset Manager Minority
G.N. Tech Venture Capital Venture Capital Minority
Hanlim Pharm Corporation Minority
Industrial Bank of Korea PE/Buyout Minority
Magna Investment (Seoul) Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Altos Biologics FAQs

  • When was Altos Biologics founded?

    Altos Biologics was founded in 2020.

  • Where is Altos Biologics headquartered?

    Altos Biologics is headquartered in Seoul, South Korea.

  • What is the size of Altos Biologics?

    Altos Biologics has 16 total employees.

  • What industry is Altos Biologics in?

    Altos Biologics’s primary industry is Biotechnology.

  • Is Altos Biologics a private or public company?

    Altos Biologics is a Private company.

  • What is Altos Biologics’s current revenue?

    The current revenue for Altos Biologics is .

  • How much funding has Altos Biologics raised over time?

    Altos Biologics has raised $164M.

  • Who are Altos Biologics’s investors?

    DS Asset Management, G.N. Tech Venture Capital, Hanlim Pharm, Industrial Bank of Korea, and Magna Investment (Seoul) are 5 of 8 investors who have invested in Altos Biologics.

  • When was Altos Biologics acquired?

    Altos Biologics was acquired on 06-Oct-2026.

  • Who acquired Altos Biologics?

    Altos Biologics was acquired by Alteogen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process